New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 3, 2013
09:00 EDTCNATConatus Pharmaceuticals rises 21.3%
Conatus Pharmaceuticals is up 21.3%, or $1.31, to $7.45
News For CNAT From The Last 14 Days
Check below for free stories on CNAT the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
April 24, 2014
10:42 EDTCNATSummer Street chief scientific officer holds an analyst/industry conference call
Chief Scientific Officer Classen discusses Conatus Pharmaceuticals' Emricasan for treating assorted liver diseases on an Analyst/Industry conference call to be held on April 24 at 11 am.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use